Neuropeptides in the Humane Intra- og Extracerebral Circulation.
NCT ID: NCT00399633
Last Updated: 2008-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2007-01-31
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Inflammation and Vasodilatation in PACAP38-induced Headache Using MRI on Healthy Subjects
NCT03585894
Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs
NCT00272896
The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients
NCT04260035
PACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine
NCT03881644
Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
NCT01637662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sumatriptan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-50 years,
* 50-100 kg.
* Fertile women must use birth control.
Exclusion Criteria
* Daily intake of medicine except birth control
* Pregnancy
* Hypertension
* Hypotension
* other chronic disease
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glostrup University Hospital, Copenhagen
OTHER
Bispebjerg Hospital
OTHER
Danish Headache Center
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jakob Møller Hansen, MD
Role: PRINCIPAL_INVESTIGATOR
Danish Headache Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish Headache Center
Glostrup, Copenhagen, Copenhagen, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neuropeptide2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.